Entero Therapeutics Total Current Liabilities

Entero Therapeutics (ENTO) currently reports a total current liabilities of $14M as of June 2026. That compares with $30M in the prior-year period — down 52.3% year over year. Use the charts on this page to explore Entero Therapeutics's total current liabilities history and peer comparisons.

Entero Therapeutics's total current liabilities decreased from $30M to $14M — a 52.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Entero Therapeutics reported $14M in total current liabilities as of June 2026. That compares with $30M in the prior-year period — down 52.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Entero Therapeutics, and consider following ENTO for alerts when major investors trade the stock.